Does the Biden Administration Plan to Ignore Federal Court Ruling on Abortion Pills?

The Biden administration is now in a very difficult spot after Matthew Kacsmaryk, U.S. District Judge, revoked FDA approval for Mifepristone, an abortion pill. Kacsmaryk, in a 67-page decision, “argued that FDA failed to evaluate psychological and long-term health effects of the abortion pills, which the agency had previously declared were safe and effective.” But what will happen in the interim?

Mifepristone is a drug that has been around for more than two decades. This drug is available in 60 countries. During Friday’s press conference before the ruling was made, White House Press Secretary Karine Jean-Pierre stated that this drug is an FDA-authorized substance. “We’re going prepare for all the possible scenarios — that’s the promise I can make to the American people. That’s what my statement here is — to ensure that women have access to this drug — that they have access to it.”

The ruling is an outrage for the pro-abortion Left, and Biden has a moral obligation to ignore it.

Senator Ron Wyden (D-Ore.), stated last week that there is no legal basis for this decision. It is instead rooted in the conservatives’ undemocratic and dangerous takeover of our nation’s institutions. Whatever happens over the next seven days, I believe that the Food and Drug Administration can ignore this ruling. That’s why I’m calling again on President Biden and FDA to do so.”

He was not the only one.

Rep. Alexandria Ocasio-Cortez (D-N.Y.), stated that she believes the Biden administration should ignore this ruling. “It is up to the Biden administration to decide whether to enforce a decision.”

It seems that they may be considering doing exactly that. Xavier Becerra (Health and Human Services Secretary), who is well-known for his support for abortion, did not dismiss the possibility that the administration might ignore Kacsmaryk’s ruling. Biden didn’t dispute AOC’s request that he ignores the ruling when questioned about it.

“Everything is on offer.” That was the president’s view back in Dobbs’s day. Becerra stated that all options are on the table. “An appeals court or the Supreme Court, any court that has to see this must understand that the ruling of this single judge invalidates not only access to mifepristone but also possibly other drugs.”

This is obviously a dangerous suggestion and could set a dangerous precedent for future administrations not paying attention to court rulings that they don’t like.